Novartis Recalls 100 mg Sandimmune and Neoral Blister Packages for Packaging Defect
Novartis is recalling 100 mg Sandimmune and Neoral blister packages because they fail child-resistant packaging requirements, posing a poisoning risk to children.
- Product
- Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules prescription drug blister packages
- Category
- Drug
- Distribution
- Distributed nationwide